Lateral Flow Test Strip with Parallel Antigen Lanes for Parasitic Disease Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tests for Chagas disease, Leishmaniasis, and Heartworm in veterinary medicine suffer from high false positive and false negative results, and lack a rapid and accurate detection method, particularly in dogs, where existing tests are limited by sensitivity and specificity issues.
Innovation Solution
A diagnostic test using specific antigen combinations and configurations in immunoassay formats that include multiple antigens from Trypanosoma cruzi, Leishmania species, and Dirofilaria immitis, applied in a rapid detection immunoassay method with parallel lanes on test strips, allowing for simultaneous detection of antibodies in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a single antigen is used in the diagnostic test, then the test is simple and quick, but the sensitivity and specificity are insufficient leading to high false positive and false negative results
Solution Approach 1:
The patent divides the diagnostic test into multiple parallel lanes, with each lane containing a different antigen (e.g., T. cruzi antigen, Leishmania antigen, Dirofilaria antigen). This segmentation allows simultaneous detection of multiple pathogens while maintaining a simple lateral flow format, resolving the contradiction between diagnostic accuracy and test complexity.
Solution Approach 2:
The test strip functions as a composite diagnostic system integrating multiple antigens, detection antibodies, and control mechanisms in a single device. This composite structure enables multi-pathogen detection with high sensitivity and specificity without requiring multiple separate tests, thus improving reliability while managing complexity.
2Measurement precision
If multiple antigens are used in parallel lanes, then the sensitivity and specificity improve reducing false results, but the device complexity increases
Solution Approach 1:
The lateral flow test strip is designed as a universal platform that can detect multiple different pathogens simultaneously through parallel lanes. Each lane is optimized for a specific pathogen but the overall device structure and operating procedure remain uniform, allowing high measurement precision without proportionally increasing operational complexity.
Solution Approach 2:
The patent combines multiple single-antigen tests into a single multi-antigen test strip by merging the detection functions in parallel lanes. This consolidation improves measurement precision through multi-pathogen detection while reducing the need for multiple separate testing procedures, thereby managing overall device complexity.
3Productivity
If traditional immunofluorescence assay is used, then the equipment is simple, but the testing time is long and cannot be completed rapidly during a regular appointment
Solution Approach 1:
The patent replaces the mechanical and time-intensive immunofluorescence assay with a lateral flow immunoassay that uses capillary action and visual detection. This substitution eliminates the need for complex incubation steps, washing procedures, and fluorescence microscopy equipment, enabling rapid results within minutes during a regular veterinary appointment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly reduces false positive and false negative results, providing a rapid and accurate detection of these parasitic diseases, improving sensitivity and specificity, and enabling simultaneous testing for multiple pathogens.
Implementation Method 1
determining the presence or absence of antibodies against the target parasite by detecting immunobinding of the antigens within each subset to antibodies against said target parasites
Data Source
AI summary
Among several illnesses common to pets such as dogs that can also affect humans, American trypanosomiasis, commonly known as Chagas disease, is a parasitic 20 condition caused by the hemoflagellated protozoa, Trypanosoma cruzi. Active transmission is through triatomine vectors known as kissing bugs, which are prevalent in North and South America. Diagnostic methods, systems, test strips, test kits, and other immunoassay materials are provided for the detection of antibodies to one or more specific parasites of veterinary and human concern in biological samples, including those that are responsible for Chagas disease (Trypanosoma cruzi), Leishmaniasis (Leishmania infantum), and Heartworm (Dirofilaria immitis).


